Join us on Thursday, Oct. 29 for Insights and Innovations in Biomedical Research, held at Temple University School of Medicine's New Medical Education and Research Building (3500 N. Broad St., Philadelphia).
Thursday, October 29, 2009
Insights and Innovations in Biomedical Research
(CME accredited)
8–8:30 AM: Coffee / Registration
8:30–11:30 AM:
Series I: AIDS
Luo Auditorium, 2 CME credits
The Challenge of Curing HIV
Roger Pomerantz, MD
HIV/AIDS: Progress, Pitfalls and Promise
Ellen Tedaldi, MD
Genetic Variation, Transcription and HIV Disease
Brian Wigdahl, PhD
Altered Monocyte/Macrophage Homeostasis in AIDS and NeuroAIDS
Tracy Fischer-Smith, PhD
Series II: Cancer
Lachman Auditorium, 2.75 CME credits
Cancer as an Organ System: The Tumor Microenvironment
John Niederhuber, MD
Targeting the Cell Cycle Machinery for Cancer Therapy
E. Premkumar Reddy, PhD
The Comprehensive Neuro-Oncology Center: Challenges and Opportunities
Ray Sawaya, MD
Protein Toxin Conjugates for Brain Tumor Therapy
Douglas Laske, MD
11:30–12:30 PM: Boom or Bust: Overcoming Whiplash in Science Policy
Shirley Tilghman, PhD ’75
President, Princeton University
12:30–2 PM
Lunch, Stone Commons
Poster Session, Room 319
2–5 PM
Series I: Neuroscience
Luo Auditorium, 3 CME credits
Multipotential Progenitor Cells from the Human Brain: Differentiation Predicts Viral Susceptibility
Eugene Major, PhD
Synthetic Cannabinoids as a Potential Therapy for Central Nervous System Injury
Ronald Tuma, PhD
Neural Stem Cells Interactions with the Immune System
Samia Khoury, MD
Stem and Progenitor Cell-Based Treatment of Myelin Disorders
Steve Goldman, MD, PhD
State of the Art Functional Neuroradiology -- Today and Tomorrow
Scott Faro, MD
Series II: Cardiovascular
Lachman Auditorium, 3 CME credits
Calcium Mediated Cardiac Injury and Repair
Steven Houser, PhD
Novel Roles for G Protein-Coupled Receptor Kinases in Heart Failure
Walter Koch, PhD
PKCalpha as a Heart Failure Target
Jeffrey Molkentin, PhD
Cardiac Regeneration
Piero Anversa, MD
How to Make a Heart: Towards Regenerative Cardiovascular Medicine
Ken Chien, MD, PhD
5–6:30 PM:
Wine/Cheese Reception, Third Floor
Poster Session, Third Floor
For more information on course learning objectives, research poster presentations and participating faculty, visit www.temple.edu/medicine/alumni/opening_celebration.htm.
For more information on all opening celebration activities and to register online, visit myowlspace.com/medicine.
If you have special needs that we can address to make your participation more meaningful and enjoyable, please contact our office at 215.707.4787.
Questions? Call 215.707.7650 or e-mail medrsvp@temple.edu.
Target Audience: Practitioners in all specialties.
Accreditation Statement: Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for physicians.
Certification Statement: Temple University School of Medicine designates this educational activity for a maximum of 5.75 AMA Physician’s Recognition Award Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy: It is the policy of Temple University School of Medicine; The Albert J. Finestone, M.D. Office for Continuing Medical Education to insure balance, independence, objectivity and scientific rigor in all of its sponsored or jointly sponsored educational programs. All faculty, program planning committee members, and Temple University School of Medicine Continuing Medical Education staff participating in programs sponsored or jointly sponsored by Temple University School of Medicine are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Temple University School of Medicine, Temple University Health System or its affiliates. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
We gratefully wish to acknowledge Cephalon, Genentech and GeneSyn for their support of this educational program. |
